GOLDILOCKS THERAPEUTICS
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions. The company uses its proprietary mesoscale nanoparticles (MNPs) specifically target therapeutic payloads to the renal tubule epithelium. It was founded in 2018 and is based in Bedford, New York.
GOLDILOCKS THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Wellness
Founded:
2018-01-01
Address:
Bedford, New York, United States
Country:
United States
Website Url:
http://www.goldilockstherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(914) 205-3862
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Investors List
Accelerate New York Seed Fund
Accelerate New York Seed Fund investment in Seed Round - Goldilocks Therapeutics
Official Site Inspections
http://www.goldilockstherapeutics.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
- Host name: 172.67.172.84
- IP address: 172.67.172.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Goldilocks Therapeutics"
Goldilocks Therapeutics, Inc. Company Profile | Bedford, NY ...
Find company research, competitor information, contact details & financial data for Goldilocks Therapeutics, Inc. of Bedford, NY. Get the latest business insights from Dun & Bradstreet.See details»
Goldilocks Therapeutics - Org Chart, Teams, Culture & Jobs - The …
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions. The company uses its proprietary mesoscale …See details»
Goldilocks Therapeutics Company Profile | Management and
Goldilocks Therapeutics Profile and History. Goldilocks Therapeutics was formed to develop preventatives and/or treatments for acute kidney injury (AKI), polycystic kidney disease (PKD), …See details»
Goldilocks Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Goldilocks Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Goldilocks Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 1 literature.See details»
Goldilocks Therapeutics - PitchBook
Goldilocks Therapeutics General Information Description. Developer of therapeutic drugs designed to treat acute kidney injury and polycystic kidney diseases. The company's drugs specifically target therapeutic payloads to the …See details»
Goldilocks Therapeutics - CoBee Company Profile & Funding Rounds
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions. The company uses its proprietary mesoscale …See details»
Goldilocks Therapeutics Inc. - 881M1 Details - GovTribe
For Profit Organization. Goldilocks Therapeutics Inc. - 881M1 Federal Contract and Grant Award History. 881M1. Corporate Entity (Not Tax Exempt). For Profit Organization. GovTribe …See details»
Goldilocks Therapeutics - Overview, News & Similar companies
Goldilocks Therapeutics. Manufacturing · New York, United States · <25 Employees. Goldilocks Therapeutics was formed to develop preventatives and/or treatments for acute kidney injury …See details»
Goldilocks Therapeutics - Crunchbase
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»
Goldilocks Therapeutics - Company Profile - Tracxn
Goldilocks Therapeutics - Developer of therapeutic solutions for treating kidney injury, chronic kidney disease & others. from 2 investors. Founded by Arthur Klausner, Daniel Heller and 1 …See details»
Goldilocks Therapeutics - Products, Competitors, Financials, …
Goldilocks Therapeutics develops preventatives and treatments for acute kidney injury (AKI), chronic kidney disease (CKD), polycystic kidney disease (PKD), and other under-treated …See details»
Goldilocks Therapeutics | VentureRadar
Goldilocks Therapeutics is developing a novel “mesoscale” nanoparticle (MNP) drug-delivery platform that would prevent or treat kidney disease and acute kidney injury. ... Dansk Biotek …See details»
Goldilocks Therapeutics - Funding, Financials, Valuation & Investors
Jan 1, 2020 Goldilocks Therapeutics has raised 1 round. This was a Seed round raised on Jan 1, 2020 . Goldilocks Therapeutics is funded by Accelerate New York Seed Fund .See details»
Arthur Klausner - ELabNYC
Arthur Klausner is CEO of Goldilocks Therapeutics, Inc., a start-up focused on targeted renal drug delivery, initially to prevent/treat acute kidney injury. He was previously CEO of Gem …See details»
Goldilocks Therapeutics - CB Insights
Goldilocks Therapeutics has 3 executives. Goldilocks Therapeutics's current Founder, Chief Medical Officer is Edgar A. Jaimes. Name. Work History. Title. Status. Edgar A. Jaimes. …See details»
Goldilocks Therapeutics - Contacts, Employees, Board Members, …
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions.See details»
Goldilocks and the 'not great, but good enough' development deal
Feb 27, 2024 The European organization will cover 100% of a study’s cost, as well as provide a team of experts to help develop late-phase drugs. In exchange, ...See details»